August 10, 2026
Quantum BioPharma Gets FDA Green Light for Lucid-MS Phase 2 Trial in Multiple Sclerosis
August 10, 2026
PX1 Research Expands cGMP Quality Control with 99%+ HPLC Purity for US-Made Research Peptides
August 10, 2026
NanoViricides Gets Approval for Phase II Ebola Trial in DRC, Offering Oral Treatment Option
August 10, 2026
Telomir Pharmaceuticals Publishes Peer-Reviewed Data Supporting Telomir-Zn for Triple-Negative Breast Cancer
August 10, 2026
Park-Ohio’s 2Q26 Results Signal Inflection Point as Engineered Products Improves and FY26 Guidance Raised
August 10, 2026
ICON Smile Studios Expands Integrated Dental Care With New Flagship Campuses in Virginia Beach and Norfolk
August 10, 2026
Quantum BioPharma Gets FDA Green Light for Phase 2 Trial of Lucid-MS in Multiple Sclerosis
August 7, 2026
Quantum BioPharma’s Dual Strategy Targets Neurological Health with MS Drug and Alcohol Supplement
August 7, 2026
Quantum BioPharma Advances Dual Strategy for Neurological Health, Targeting MS and Alcohol Misuse
August 7, 2026
Spanish Case of Pork Tapeworm Mimicking Brain Cancer Underscores Diagnostic Challenges and Need for New Treatments
August 6, 2026
American Fusion Expands Patent Portfolio to 82 Applications, Advances Texatron Testing
August 6, 2026
Nano-X Imaging Raises $8 Million in Registered Direct Offering to Fund Working Capital and Corporate Initiatives
August 6, 2026
Liquid Biopsy Could Predict Immunotherapy Response in Advanced Lung Cancer, Study Suggests
August 6, 2026
Innovative Designs Reports Best Quarter in Company History with Near 40% Revenue Growth
August 6, 2026
July Wellness Index Report Highlights Shift Toward Working with the Body’s Own Biology
August 5, 2026
Regentis GelrinC Gains European Approval for Enhanced Manufacturing, Bolstering Its Value Proposition in Knee Cartilage Repair
August 5, 2026
Onco-Innovations Integrates AI, Nanotech, and Targeted Therapy in New Cancer Drug Development
August 5, 2026
Earth Science Tech Advances Telehealth Position Through Technology and Vertical Integration
August 5, 2026
Tonix Pharmaceuticals to Present at Upcoming Investor Conferences, Highlighting TONMYA and Pipeline
August 5, 2026
LataMed AI to Present at Universidad Santa Maria Conference on AI in Healthcare and Systems Engineering
August 4, 2026
San Francisco Dental Implant Center Highlights All-on-4 Procedure for Eligible Patients
August 3, 2026
Regentis Biomaterials Advances GelrinC as Potential First-in-Class Cartilage Repair Treatment
